I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
HDS screening with patient-derived primary cells guided ind..:
Xing He
;
Hezhong Yan
;
Jie Hu
...
https://www.frontiersin.org/articles/10.3389/fmed.2023.1212851/full. , 2023
Link:
https://doi.org/10.3389/fmed.2023.1212851
RT Journal T1 <Title>HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma–in vivo and vitro</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:838fe524021c42f2896dc9818eb10ce1&Exemplar=1&LAN=DE A1 Xing He A1 Hezhong Yan A1 Jie Hu A1 Xiaowei Duan A1 Mingjin Zhang A1 Haiqing Li A1 Jiaoxue Wang A1 Qian Gao A1 Senyuan Yu A1 Xilu Hou A1 Guobin Liao A1 Shicun Guo A1 Jin Li A1 Yurong Ge A1 Xiaolan Chen A1 Wenchao Wang A1 Jun Tang PB Frontiers Media S.A. YR 2023 K1 esophageal squamous cell carcinoma K1 high-throughput drug sensitivity screening technology K1 drug sensitivity K1 patient-derived tumor xenografts K1 therapeutic efficacy K1 Medicine (General) K1 R5-920 JF https://www.frontiersin.org/articles/10.3389/fmed.2023.1212851/full LK http://dx.doi.org/https://doi.org/10.3389/fmed.2023.1212851 DO https://doi.org/10.3389/fmed.2023.1212851 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
